[HTML][HTML] Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy

C Kothari, G Ouellette, Y Labrie, S Jacob, C Diorio… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Breast cancer (BC) is a heterogeneous disease where the survival rate of patients
decreases with progression of the disease. BC usually has a linear progression, classified …

[HTML][HTML] Genome-Wide Gene Expression Analyses of BRCA1- and BRCA2-Associated Breast and Ovarian Tumours

GAR Wiggins, LC Walker, JF Pearson - Cancers, 2020 - mdpi.com
Simple Summary Variants in the breast cancer susceptibility genes BRCA1 and BRCA2
increase the risk of developing breast and ovarian cancers. Over the past two decades …

Tree-weighting for multi-study ensemble learners

M Ramchandran, P Patil… - Pacific Symposium on …, 2019 - World Scientific
Multi-study learning uses multiple training studies, separately trains classifiers on each, and
forms an ensemble with weights rewarding members with better cross-study prediction …

[HTML][HTML] TBC1D9: an important modulator of tumorigenesis in breast cancer

C Kothari, A Clemenceau, G Ouellette, K Ennour-Idrissi… - Cancers, 2021 - mdpi.com
Simple Summary Triple negative breast cancer (TNBC) lacks the expression of hormonal
receptors estrogen and progesterone along with the over-expression of human epithelial …

[HTML][HTML] Is carboxypeptidase B1 a prognostic marker for ductal carcinoma in situ?

C Kothari, A Clemenceau, G Ouellette, K Ennour-Idrissi… - Cancers, 2021 - mdpi.com
Simple Summary Ductal carcinoma in situ (DCIS) is an early-stage breast cancer (BC), in
which tumor cells are growing in a localized duct of the mammary gland. DCIS is considered …

[HTML][HTML] An isoform of AIF1 involved in breast cancer

FA Slim, G Ouellette, K Ennour-Idrissi, S Jacob… - Cancer Cell …, 2018 - Springer
Background Inflammation is a major player in breast cancer (BC) progression. Allograft-
inflammatory factor-1 (AIF1) is a crucial mediator in the inflammatory response. AIF1 …

[HTML][HTML] Increased gene expression variability in BRCA1-associated and basal-like breast tumours

GAR Wiggins, MA Black, A Dunbier… - Breast cancer research …, 2021 - Springer
Purpose Inherited variants in the cancer susceptibility genes, BRCA1 and BRCA2 account
for up to 5% of breast cancers. Multiple gene expression studies have analysed gene …

Gene signatures of breast cancer development and the potential for novel targeted treatments

C Kothari, C Diorio, F Durocher - Pharmacogenomics, 2020 - Taylor & Francis
Breast cancer (BC) is a heterogeneous disease; a single tumor can be classified differently
according to its histological grade, stage, appearance and expression of receptors …

[HTML][HTML] Bayesian combinatorial MultiStudy factor analysis

IN Grabski, R De Vito, L Trippa… - The annals of applied …, 2023 - ncbi.nlm.nih.gov
Mutations in the BRCA1 and BRCA2 genes are known to be highly associated with breast
cancer. Identifying both shared and unique transcript expression patterns in blood samples …

Probabilistic approaches to multi-study genomic matrix decompositions and single-cell RNA-sequencing analysis

IN Grabski - 2023 - search.proquest.com
Analyzing genomic data yields critical insights into important biological and clinical
questions, but can be challenging due to noise, sparsity, and systematic sources of …